January 22 – Year-end report 2024
Alligator hosted a webinar on Wednesday, January 22, at 3 p.m. CET for investors, analysts and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the Year-end report, which was followed by a Q&A session.
The call was held in English and can be requested through the link below.
LATEST NEWS
Alligator Bioscience publishes Annual Report for 2024
Lund, Sweden, 27 March 2025 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Annual Report for 2024, as well …
Bulletin from the extraordinary general meeting in Alligator Bioscience AB
Today, on 27 March 2025, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the adopted resolutions follows …
Alligator Bioscience announces leadership transition in clinical development
Lund, Sweden – 21 March 2025 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that Dr. Sumeet Ambarkhane MD, Chi …